InvestorsHub Logo
Followers 468
Posts 26927
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 49

Friday, 01/13/2012 4:51:49 PM

Friday, January 13, 2012 4:51:49 PM

Post# of 116
Onyx Pharmaceuticals' CFO say company attractive target, Bloomberg reports
Theflyonthewall.comTheflyonthewall.com –

Matt Fust, the CFO of Onyx Pharmaceuticals (ONXX), which developed the kidney cancer drug Nexavar, said the company is an attractive target for acquirers because it may receive regulatory approvals for several new treatments during the next year, reports Bloomberg.


surf's up......crikey